Table 6.

Treatment of Manifestations in Individuals with Classic or Nonclassic WFS1 Spectrum Disorder

Manifestation/ConcernTreatmentConsiderations/Other
Diabetes mellitus Routine practice for insulin-dependent DM
  • Diabetic ketoacidosis is rare.
  • Because episodes of severe hypoglycemia are common, 1 insulin is given as multiple daily injections or continuous infusion by insulin pump.
  • Continuous glucose monitoring w/hypoglycemia alarm is recommended due to risk for hypoglycemic episodes.
  • Other hypoglycemic agents are not licensed for use in WFS1-SD (due to insufficient evidence for efficacy or safety).
Optic atrophy Correction of refractive error
Low-vision services
  • Evaluate for visual aids.
  • Community vision services through early intervention or school district
Sensorineural hearing
impairment
Treatment of SNHL depends on degree of hearing impairment. 2
Activities of daily living Vision impairment supportCommunication training (e.g., Braille), walking aids
Occupational therapist
  • To support tasks incl mobility & ADL
  • To assist w/household modifications if needed
Dysphagia Speech-language therapist
  • Determine exact cause of swallowing malfunction.
  • Modify food types & consistency, head positioning during swallowing, & exercises to ensure safe swallow.
Dentist/dental hygienistAttention to oral hygiene & dental care
Dysarthria Speech-language pathologistHelp maintain vocal control, improve speech, teach breathing techniques, & assist communication in general.
Central apnea Respiratory teamOptions incl overnight noninvasive ventilatory support.
Psychiatric Per standard treatment by psychiatric professional (psychiatrist, psychologist, neuropsychologist) as neededPharmacologic & non-pharmacologic therapies available.
Neurogenic bladder
  • Anticholinergic drugs
  • Clean intermittent self-catheterization or indwelling catheter
  • Treatment of recurrent urinary tract infections
  • Detrusor muscle dyssynergia may require pharmacologic relaxants or stimulants at different stages.
  • Ensure central diabetes insipidus is screened for & treated.
Bowel dysfunction Dietary mgmtIn conjunction w/bladder dysfunction
Other
endocrine
findings
Diabetes
insipidus
Per standard treatmentCare w/arginine vasopressin replacement to avoid hyper-/hyponatremia
Hypogonadism Hormone replacement therapy
Hypothyroidism Thyroid hormone replacement
Growth
restriction
Evaluate for growth hormone supplementation according to national guidelines for growth hormone therapy.
Transition of care to adult
service providers
Assess understanding of illness, capacity for independent life skills
  • Start from early in 2nd decade.
  • Involve young person as well as care providers in planned transfer to adult services.
Family/Community
  • Ensure appropriate social services involvement to connect families w/local resources, respite, & support.
  • Coordinate care to manage multiple subspecialty appointments, equipment, medications, & supplies.
Consider support w/adaptive sports, higher education, & employment opportunities.

ADL = activities of daily living; DM = diabetes mellitus; SNHL = sensorineural hearing loss; WFS1-SD = WFS1 spectrum disorder

1.
2.

See Genetic Hearing Loss Overview for details about treatment options.

From: WFS1 Spectrum Disorder

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.